Morgan Stanley Maintains Equal-Weight on Clorox, Maintains $160 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Dara Mohsenian maintains an Equal-Weight rating on Clorox (CLX) and keeps the price target at $160.

March 26, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley maintains an Equal-Weight rating on Clorox with a $160 price target.
The maintenance of an Equal-Weight rating and a steady price target by a major analyst like Morgan Stanley suggests a neutral short-term impact on Clorox's stock. The reaffirmation indicates that the analyst sees no immediate catalysts that would significantly change the company's valuation or stock performance in the near term. Therefore, the impact is neutral, reflecting stability in the analyst's outlook.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100